ESR2 and glioblastoma: Various recent studies have indicated the great significance of aberrant ERβ expression in human glioma, its decreasing expression in high-grade tumors, and the inhibitory effect of ERβ agonist on the proliferation of glioblastoma cell lines [12, 21].